Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4

Dawn E. Post*, Eric M. Sandberg, Michele M. Kyle, Narra Sarojini Devi, Daniel J. Brat, Zhiheng Xu, Mourad Tighiouart, Erwin G. Van Meir

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4'. Together they form a unique fingerprint.

Medicine & Life Sciences